… in patients hospitalized with Covid-19, we randomly assigned 1561 patients to receive
hydroxychloroquine and 3155 to receive usual care. The primary outcome was 28-day mortality. …

… Using a centralized electronic system, we randomly assigned enrolled patients to
hydroxychloroquine or placebo in a 1:1 ratio stratified by enrolling hospital using randomization …

… The main objective of the study was to assess the effect of HCQ on mortality in hospitalized
patients with COVID-19. Outcomes for the analyses were extracted from studies which met …

… center, hydroxychloroquine was suggested as treatment for hospitalized patients with Covid-…
resting oxygen saturation, during the period in which patients in this report were admitted. …

… Hydroxychloroquine and chloroquine show only modest antiviral activity in cellculture …
activity of hydroxychloroquine would affect disease progression in hospitalized patients. Peter …

… role of both hydroxychloroquine or lopinavir-ritonavir among hospitalized patients via the …
did not play a role in patients with advanced disease who were hospitalized. Similarly, there …

… the efficacy and safety of hydroxychloroquine as treatment for hospitalized COVID-19. … )
evaluating hydroxychloroquine as treatment for hospitalized COVID-19 patients were searched …

… diagnosed with COVID-19 pneumonia in our hospital, none were receiving HCQ treatment
before admission. All predicting the use of HCQ in SARS-CoV-2 infections. As one of the …

… 14 cohort studies were included (20 979 patients). Thirteen studies (1 RCT and 12 cohort
studies) with 15 938 hospitalized patients examined the effect of HCQ on short-term mortality. …

… in patients hospitalized with Covid-19, we randomly assigned 1561 patients to receive
hydroxychloroquine and 3155 to receive usual care. The primary outcome was 28-day mortality. …